Search results
mRNA Therapeutics Market is Estimated to be USD 45.85 billion by 2031; Driven by Innovative...
Digital Journal· 2 weeks agoAccording to SNS Insider, the mRNA Therapeutics market will be reaching USD 45.85 billion by 2031 and will be growing at a CAGR of 1.7% over the forecast period of 2024-2031 ...
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Digital Journal· 6 days ago(NASDAQ:MRNA) today announced that the Company will present data from its respiratory portfolio, including vaccines and vaccine candidates against COVID-19 (mRNA& ...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 1 week agoResearchers also detected a statistical signal for seizures after vaccination with the BNT162b2...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 1 week agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people
We May Be Facing an Epidemic of This Brain Disease
Mercola· 3 days agoAccording to mounting data, one of the more serious side effects of the COVID mRNA jabs appears to be dementia, and worse yet, this previously untransmissible disease may ...
Uveitis History Linked to Recurrence After COVID Vaccination
MedPage Today· 7 days agoPeople with a history of uveitis were more likely to experience recurrences of the potentially...
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape· 1 week agoMany clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.